Mignone Roberto insider trades
Mignone Roberto has filed 29 Form 4s with the SEC that we hold, for Teva Pharmaceutical Industries LTD (TEVA) (Director) and Guardant Health, Inc. (GH) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $38.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($22.8M). The largest single trade was a sale of 367,600 shares of Teva Pharmaceutical Industries LTD worth $14.4M, dated 2026-09-18. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-06-16 and the latest 2026-09-22.
Teva Pharmaceutical Industries LTD (TEVA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-18 | S, sale reported on Form 4 | 519,000 | $8.8M | 2024-06-21 |
| 2024-12-20 | S, sale reported on Form 4 | 286,000 | $6.3M | 2024-12-26 |
| 2025-11-06 | S, sale reported on Form 4 | 200,000 | $4.8M | 2025-11-10 |
| 2025-11-26 | S, sale reported on Form 4 | 50,000 | $1.3M | 2025-12-01 |
| 2025-12-16 | S, sale reported on Form 4 | 77,400 | $2.3M | 2025-12-18 |
| 2026-09-18 | S, sale reported on Form 4 | 367,600 | $14.4M | 2026-09-22 |
Guardant Health, Inc. (GH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1258394) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms